Comparison of drug delivery from conventional versus 'Venturi' nebulizers

European Respiratory Journal

Volumn 10, Issue 11, 1997, Pages 2479-2483

  Devadason, S G ^a,b   Everard, M L ^a   Linto, J M ^a   Le Souef P N ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Aerosol therapy; Drug delivery; Inhalation systems; Nebulizer output

Indexed keywords

SALBUTAMOL;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MEDICAL NEBULIZER; NEBULIZATION; PARTICLE SIZE; PRIORITY JOURNAL; ULTRAVIOLET SPECTROPHOTOMETRY;

ADMINISTRATION, INHALATION; ADOLESCENT; AEROSOLS; AGE FACTORS; ALBUTEROL; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 0031445242     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10112479     Document Type: Article

References (19)

1. Dolovich M. Physical principles underlying aerosol therapy. J Aerosol Med 1989; 2: 171-185.
2. Johnson MA, Newman SP, Bloom R, Talaee N, Clarke SW. Delivery of albuterol and ipatropium bromide from two nebuliser systems in chronic stable asthma: efficacy and pulmonary deposition. Chest 1991; 99: 1139-1144.
3. Thomas SHL, O'Doherty MJ, Page CJ, Nunan TO, Bateman NT. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur Respir J 1991; 4: 616-622.
4. Thomas SHL, O'Doherty MJ, Page CJ, Nunan TO. Variability in the measurement of nebulised aerosol deposition in man. Clin Sci 1991; 81: 767-775.
5. Chua HL, Collis GG, Newbury AM, et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994; 7: 2185-2191.
6. Mukhopadhyay S, Staddon GE, Eastman C, Palmer M, Rhys Davies E, Carswell F. The quantitative distribution of nebulised antibiotic in the lungs in cystic fibrosis. Respir Med 1994; 88: 203-211.
7. Collis GG, Cole CH, Le Souëf PN. Dilution of nebulised aerosols by air entrainment in children. Lancet 1990; 336: 341-343.
8. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulisers. Arch Dis Child 1992; 67: 586-591.
9. Gonda I. Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract. Crit Rev Ther Drug Carrier Syst 1990; 6: 273-313.
10. Nikander K. Drug delivery systems. J Aerosol Med 1994; 7 (Suppl. 1): S19-24.
11. Newman SP, Pitcairn GR, Hooper G, Knoch M. Efficient drug delivery to the lungs from continuously operated open-vent nebuliser and low pressure compressor system. Eur Respir J 1994; 7: 1177-1181.
12. Thomas SHL, Langford JA, George RDG, Geddes DM. Improving the efficiency of drug administration with jet nebulisers. Lancet 1988; i: 126.
13. Marshall LM, Francis PW, Khafagi FA. Aerosol deposition in cystic fibrosis using an aerosol conservation device and a conventional jet nebulizer. J Paediatr Child Health 1994; 30: 65-67.
14. Mercer TT, Goddard RF, Flores RL. Effect of auxiliary air flow on the output characteristics of compressed-air nebulisers. Ann Allergy 1969; 27: 211-217.
15. Knoch M, Wunderlich E, Geldner S. A nebulizer system for highly reproducible aerosol delivery. J Aerosol Med 1994; 7: 229-237.
16. Newnham DM, Lipworth BJ. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax 1994; 49: 762-770.
17. Dennis JH. Drug nebuliser design and performance: breath enhanced jet vs constant output jet vs ultrasonic. J Aerosol Med 1995; 8: 277-280.
18. Barry PW, O'Callaghan C. The output of budesonide from nebulisers. In: Drug Delivery to the Lungs 1995; VI: pp. 98-101.
19. Brain JB, Valberg PA. State of the art: deposition of aerosol in respiratory tract. Am Rev Respir Dis 1979; 120: 1325-1371.